MMP2 and neoplasm: Altogether, our results demonstrate that kahweol is a potent anti-angiogenic compound both in vitro and in vivo, targeting some key steps shared with tumor progression, key molecules involved in ECM remodeling (MMP-2 and uPA), and key molecules involved in inflammation (COX-2 and MCP-1).